Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 350
Filtrar
Más filtros










Filtros aplicados
Intervalo de año de publicación
1.
BMC Pregnancy Childbirth ; 21(1): 826, 2021 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-34903199

RESUMEN

BACKGROUND: Postpartum depression affects a significant proportion of women of childbearing age. The birth of a newborn baby is normally considered a joyful event, inhibiting mothers from expressing their depressive feelings. If the condition is not well understood and managed, mothers with postpartum depression are likely to experience suicidal ideation or even commit suicide. This study explored lived experiences of women who had recovered from a clinical diagnosis of postpartum depression in southwestern Uganda. METHODS: This phenomenological study adopted the explorative approach through in-depth interviews as guided by the biopsychosocial model of depression. It was conducted in Mbarara Regional Referral Hospital, Bwizibwera Health Centre IV and Kinoni Health Centre IV located in Mbarara and Rwampara districts, southwestern Uganda. Data were collected from 30 postpartum mothers who were purposively selected, between 9th December 2019 and 25th September 2020. We analyzed this work using thematic data analysis and this was steered by the Colaizzi's six-step phenomenological approach of inquiry. RESULTS: The findings were summarized into five major themes: 1) somatic experiences including insomnia and headache, breast pain, poor breast milk production, weight loss and lack of energy; 2) difficulties in home and family life including overwhelming domestic chores, lack of social support from other family members, fighting at home and financial constraints due to COVID-19 pandemic; 3) negative emotions including anger, self-blame, despondency and feelings of loneliness and regrets of conceiving or marriage; 4) feelings of suicide, homicide and self-harm including suicidal ideation and attempt, homicidal ideations and attempt and feelings of self-harm and 5) coping with postpartum depression including spirituality, termination of or attempt to leave their marital relationships, acceptance, counselling and seeking medical treatment, perseverance. CONCLUSION AND RECOMMENDATIONS: Suicidal and homicidal thoughts are important parts of the postpartum depression experience, and these may put the lives of the mothers, their spouses and their babies at a great risk. Poor relationship quality, intimate partner violence and lack of financial resources contribute significantly to the negative emotional experiences of mothers with PPD.


Asunto(s)
COVID-19 , Depresión Posparto , Estrés Financiero , Matrimonio/psicología , Distanciamiento Físico , Estrés Psicológico , Ideación Suicida , Adaptación Psicológica , Adulto , COVID-19/epidemiología , COVID-19/prevención & control , COVID-19/psicología , Control de Enfermedades Transmisibles/métodos , Depresión Posparto/diagnóstico , Depresión Posparto/fisiopatología , Depresión Posparto/psicología , Femenino , Estrés Financiero/etiología , Estrés Financiero/psicología , Humanos , Modelos Biopsicosociales , Investigación Cualitativa , SARS-CoV-2 , Apoyo Social/psicología , Estrés Psicológico/complicaciones , Estrés Psicológico/etiología , Estrés Psicológico/fisiopatología , Uganda/epidemiología
2.
Resuscitation ; 169: 229-311, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34933747

RESUMEN

The International Liaison Committee on Resuscitation initiated a continuous review of new, peer-reviewed published cardiopulmonary resuscitation science. This is the fifth annual summary of the International Liaison Committee on Resuscitation International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations; a more comprehensive review was done in 2020. This latest summary addresses the most recently published resuscitation evidence reviewed by International Liaison Committee on Resuscitation task force science experts. Topics covered by systematic reviews in this summary include resuscitation topics of video-based dispatch systems; head-up cardiopulmonary resuscitation; early coronary angiography after return of spontaneous circulation; cardiopulmonary resuscitation in the prone patient; cord management at birth for preterm and term infants; devices for administering positive-pressure ventilation at birth; family presence during neonatal resuscitation; self-directed, digitally based basic life support education and training in adults and children; coronavirus disease 2019 infection risk to rescuers from patients in cardiac arrest; and first aid topics, including cooling with water for thermal burns, oral rehydration for exertional dehydration, pediatric tourniquet use, and methods of tick removal. Members from 6 International Liaison Committee on Resuscitation task forces have assessed, discussed, and debated the quality of the evidence, according to the Grading of Recommendations Assessment, Development, and Evaluation criteria, and their statements include consensus treatment recommendations or good practice statements. Insights into the deliberations of the task forces are provided in Justification and Evidence-to-Decision Framework Highlights sections. In addition, the task forces listed priority knowledge gaps for further research.


Asunto(s)
COVID-19 , Reanimación Cardiopulmonar , Servicios Médicos de Urgencia , Paro Cardíaco Extrahospitalario , Adulto , Niño , Consenso , Primeros Auxilios , Humanos , Lactante , Recién Nacido , Paro Cardíaco Extrahospitalario/terapia , SARS-CoV-2
3.
Acta Med Port ; 34(7-8): 507-516, 2021 Jun 30.
Artículo en Portugués | MEDLINE | ID: mdl-34851815

RESUMEN

INTRODUCTION: Due to growing evidence suggesting COVID-19 may have a benign course in the newborn, a number of guidelines supporting rooming-in and breastfeeding were developed. The main aim of the study was to assess the safety of this approach, through the risk of developing severe neonatal infection. MATERIAL AND METHODS: Prospective observational study from April 2020 to February 2021 on the approach and neonatal follow-up of infants born to mothers with COVID-19 at the time of delivery in a hospital with advanced neonatal care, where rooming in and breastfeeding were promoted whenever possible. We collected data during hospital admission and over the phone during the neonatal period. RESULTS: We included 77 infants born to mothers with COVID-19 (3.8% of newborns born during the time of study), median gestational age 39 weeks + 5 days and median birth weight 3270 g; 9% were born premature (versus 12% born premature among newborns born during the time of study). Rooming-in took place in all of them although 4% were briefly admitted to the Neonatal Intensive Care Unit; 88% were discharged home up to day three, 97% were breastfed at the time of discharge and 90% were still breastfed by the end of the neonatal period. We completed neonatal follow-up of 63 newborns, eight of them developed COVID-associated symptoms, three with need of medical evaluation; 40% had no medical assessment after being discharged. Out of 77, 5% of infants were infected with SARS-CoV-2 (total of four, one mild, three asymptomatic), with no significant differences during hospital stay or follow-up. DISCUSSION: Neonatal infection was uncommon and mild, and there was no increase in prematurity. Rooming-in and breastfeeding were safe and should be promoted whenever clinically possible. Follow-up care after hospital discharge needs improvement. CONCLUSION: Infants born to mothers with COVID-19 were safely roomed in with their mothers and exclusively breastfed.


Introdução: Dada a evidência crescente de maior benignidade da COVID-19 no recém-nascido, surgiram recomendações de promoção do alojamento conjunto e da amamentação. O principal objetivo do estudo foi avaliar a segurança dessa abordagem, através do risco de infeção neonatal grave.Material e Métodos: Estudo observacional prospetivo de abril 2020 a fevereiro 2021 da abordagem hospitalar e seguimento após a alta dos recém-nascidos de mãe com COVID-19 num hospital com apoio perinatal diferenciado, onde foram advogados o alojamento conjunto e amamentação, sempre que possível. Recolhemos os dados no internamento e em seguimento telefónico durante o período neonatal.Resultados: Incluímos 77 recém-nascidos de mãe com COVID-19 (3,8% do total de recém-nascidos), com medianas de idade gestacional 39 semanas e 5 dias e 2370 g de peso à nascença; destes, 9% nasceram pré-termos (versus 12% pré-termos no total de recém-nascidos). Todos estiveram em alojamento conjunto e 4% foram admitidos transitoriamente na Unidade de Cuidados Intensivos Neonatais; um total de 88% recém-nascidos tiveram alta até ao terceiro dia de vida, 97% tiveram alta sob aleitamento materno e 90% mantinham-no no fim do período neonatal. Dos 63 recém-nascidos com seguimento telefónico completo, oito tiveram sintomas compatíveis com COVID-19, três dos quais com observação médica. Em 40% dos casos não houve consulta médica de vigilância após a alta. Houve 5% recém-nascidos com COVID-19 (num total de quatro, registámos um quadro ligeiro e três assintomáticos), sem particularidades no internamento ou seguimento.Discussão: A infeção neonatal foi incomum, não houve quadros graves nem maior incidência de prematuridade. O alojamento conjunto e a amamentação foram práticas seguras, devendo ser promovidas desde que clinicamente possível. Destacamos que a vigilância de saúde após a alta necessita de ser melhorada.Conclusão: Os recém-nascidos de mãe com COVID-19 podem ser mantidos em alojamento conjunto e sob aleitamento materno exclusivo.


Asunto(s)
Lactancia Materna , COVID-19 , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Madres , SARS-CoV-2
4.
Arch Cardiol Mex ; 91(Supl): 64-73, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34968378

RESUMEN

La pandemia de COVID-19 ha infligido grandes estragos a la población y en especial al personal de salud. Los esfuerzos de reanimación exigen modificaciones potenciales de las guías internacionales existentes de reanimación cardiopulmonar (RCP) debido al elevado índice de contagiosidad del virus SARS-CoV-2. Se considera que hasta 15% de los casos de COVID-19 tiene una enfermedad grave y 5% padece un trastorno crítico con una mortalidad promedio del 3%, la cual varía según sean el país y las características de los pacientes. La edad y las comorbilidades como la hipertensión arterial, enfermedad cardiovascular, obesidad y diabetes incrementan la mortalidad hasta 24%. También se ha informado un aumento reciente del número de casos de paro cardíaco extrahospitalario (PCEH). Aunque el paro cardíaco (PC) puede ser efecto de factores diversos en estos pacientes, en la mayoría de los casos se ha demostrado que el origen es respiratorio, con muy pocos casos de causa cardíaca. Se debe considerar la indicación de iniciar o continuar las maniobras de RCP por dos razones fundamentales: la posibilidad de sobrevida de las víctimas, que hasta la fecha se ha registrado muy baja, y el riesgo de contagiar al personal de salud, que es muy alto.The COVID-19 pandemic is having a large impact on the general population, but it has taken a specially high toll on healthcare personnel. Resuscitation efforts require potential modifications of the present Cardiopulmonary Resuscitation (CPR) international guidelines because of the transmissibility rate of the new SARS-CoV 2 virus. It has been seen that up to 15% of COVID-19 patients have a severe disease, 5% have a critical form of infection and the mean death rate is 3%, although there are significant differences according to the country that reports it and patients' baseline conditions that include age, presence of arterial hypertension, cardiovascular disease, diabetes or obesity. In these high risk subjects, mortality might go up to 24%. There are also reports of a recent increase in out-of-hospital cardiopulmonary arrest (OHCA) victims. Cardiac arrest (CA) in these subjects might be related to many causes, but apparently, that phenomenon is related to respiratory diseases rather than cardiac issues. In this context, the decision to start or continue CPR maneuvers has to be carefully assessed, because of the low survival rate reported so far and the high contagion risk among healthcare personnel.


Asunto(s)
COVID-19 , Paro Cardíaco , Adulto , COVID-19/complicaciones , Cardiología , Niño , Paro Cardíaco/terapia , Paro Cardíaco/virología , Humanos , Recién Nacido , México , Pandemias , Estudios Retrospectivos , SARS-CoV-2
5.
Rev. enferm. UERJ ; 29: e61623, jan.-dez. 2021. tab
Artículo en Portugués | LILACS-Express | LILACS, BDENF - Enfermería | ID: biblio-1365784

RESUMEN

RESUMO Objetivo determinar a prevalência e analisar os fatores associados ao contato pele a pele precoce e à amamentação na primeira hora de vida em tempos de COVID-19. Método estudo transversal realizado em hospital municipal na baixada litorânea do Rio de Janeiro, mediante dados de prontuários. Adotaram-se teste de Qui-Quadrado e Regressão Logística. Protocolo de pesquisa aprovado pelo Comitê de Ética em Pesquisa. Resultados entre 187 prontuários, a prevalência do contato pele a pele e da amamentação na primeira hora foram, respectivamente, 36,7% e 63,2%. Puérperas com um ou dois filhos e recém-nascidos do sexo feminino apresentaram mais chances de o bebê não ser colocado ao seio. A amamentação na primeira hora foi aproximadamente 4,5 vezes maior entre recém-nascidos colocados em contato pele a pele. Conclusão as prevalências das práticas investigadas foram insatisfatórias. A quantidade de filhos anteriores e o sexo do bebê mativeram-se associados ao contato pele a pele. As práticas analisadas apresentaram associação entre si.


RESUMEN Objetivo determinar la prevalencia y analizar los factores asociados con el contacto temprano piel a piel y la lactancia en la primera hora de vida en tiempos de COVID-19. Método estudio transversal realizado en un hospital municipal de la costa de Río de Janeiro, basado en registros médicos. Se adoptaron la prueba Chi-Cuadrado y la Regresión logística. El Comité de Ética en Investigación aprobó los protocolos utilizados. Resultados entre 187 registros, la prevalencia de contacto piel a piel y lactancia materna en la primera hora fue, respectivamente, el 36,7% y el 63,2%. Las puérperas con uno o dos hijos y las niñas recién nacidas tienen más probabilidad de que su bebé no le sea puesto en el pecho. La lactancia en la primera hora fue aproximadamente 4,5 veces más alta entre los recién nacidos puestos en contacto piel a piel. Conclusión la prevalencia de las prácticas investigadas no fue satisfactoria. El número de hijos anteriores y el sexo del bebé permanecieron asociados con el contacto piel a piel. Las prácticas analizadas se asociaron entre sí.


ABSTRACT Objective to determine the prevalence and analyze the factors associated with early skin-to-skin contact and breastfeeding in the first hour of life in times of COVID-19. Method cross-sectional study carried out in a municipal hospital in the coast of Rio de Janeiro, using data from medical records. The Chi-Square Test and Logistic Regression were used. Research ptotocol approved by the Ethic Committee. Results among 187 medical records, the prevalence rates of skin-to-skin contact and breastfeeding in the first hour were, respectively, 36.7% and 63.2%. Postpartum women with one or two children and female newborns had more chances of the baby not being placed at the breast. Breastfeeding in the first hour was approximately 4.5 times greater among newborns placed in skin-to-skin contact. Conclusion the prevalence of the analyzed practices was not satisfactory. Number of previous children and the baby's sex remained associated with skin-to-skin contact. The practices analyzed were associated with each other.

6.
Rev. enferm. UERJ ; 29: e61623, jan.-dez. 2021.
Artículo en Inglés, Portugués | LILACS-Express | LILACS | ID: biblio-1354444

RESUMEN

Objetivo: determinar a prevalência e analisar os fatores associados ao contato pele a pele precoce e à amamentação na primeira hora de vida em tempos de COVID-19. Método: estudo transversal realizado em hospital municipal na baixada litorânea do Rio de Janeiro, mediante dados de prontuários. Adotaram-se teste de Qui-Quadrado e Regressão Logística. Protocolo de pesquisa aprovado pelo Comitê de Ética em Pesquisa. Resultados: entre 187 prontuários, a prevalência do contato pele a pele e da amamentação na primeira hora foram, respectivamente, 36,7% e 63,2%. Puérperas com um ou dois filhos e recém-nascidos do sexo feminino apresentaram mais chances de o bebê não ser colocado ao seio. A amamentação na primeira hora foi aproximadamente 4,5 vezes maior entre recém-nascidos colocados em contato pele a pele. Conclusão: as prevalências das práticas investigadas foram insatisfatórias. A quantidade de filhos anteriores e o sexo do bebê mativeram-se associados ao contato pele a pele. As práticas analisadas apresentaram associação entre si.


Objective: to determine the prevalence and analyze the factors associated with early skin-to-skin contact and breastfeeding in the first hour of life in times of COVID-19. Method: cross-sectional study carried out in a municipal hospital in the coast of Rio de Janeiro, using data from medical records. The Chi-Square Test and Logistic Regression were used. Research ptotocol approved by the Ethic Committee. Results: among 187 medical records, the prevalence rates of skin-to-skin contact and breastfeeding in the first hour were, respectively, 36.7% and 63.2%. Postpartum women with one or two children and female newborns had more chances of the baby not being placed at the breast. Breastfeeding in the first hour was approximately 4.5 times greater among newborns placed in skin-to-skin contact. Conclusion: the prevalence of the analyzed practices was not satisfactory. Number of previous children and the baby's sex remained associated with skin-to-skin contact. The practices analyzed were associated with each other.


Objetivo: determinar la prevalencia y analizar los factores asociados con el contacto temprano piel a piel y la lactancia en la primera hora de vida en tiempos de COVID-19. Método: estudio transversal realizado en un hospital municipal de la costa de Río de Janeiro, basado en registros médicos. Se adoptaron la prueba Chi-Cuadrado y la Regresión logística. El Comité de Ética en Investigación aprobó los protocolos utilizados. Resultados: entre 187 registros, la prevalencia de contacto piel a piel y lactancia materna en la primera hora fue, respectivamente, el 36,7% y el 63,2%. Las puérperas con uno o dos hijos y las niñas recién nacidas tienen más probabilidad de que su bebé no le sea puesto en el pecho. La lactancia en la primera hora fue aproximadamente 4,5 veces más alta entre los recién nacidos puestos en contacto piel a piel. Conclusión: la prevalencia de las prácticas investigadas no fue satisfactoria. El número de hijos anteriores y el sexo del bebé permanecieron asociados con el contacto piel a piel. Las prácticas analizadas se asociaron entre sí.

7.
Rev. colomb. anestesiol ; 49(4): e202, Oct.-Dec. 2021. tab, graf
Artículo en Inglés | LILACS, COLNAL | ID: biblio-1341238

RESUMEN

Abstract Introduction Information regarding the clinical behavior and the anesthetic and perioperative management in pregnant patients with SARS-CoV-2 is starting to appear in the literature in the form of case reports or case series. However, strong evidence and recommendations are still limited. Objective To describe the clinical characteristics, the results of anesthetic and perioperative management, and complications in seroprevalent pregnant women for SARS-CoV-2 infection, delivered by cesarean section. Methodology Observational study in which 107 clinical records of pregnant women who were seroprevalent for SARS-CoV-2 infection were reviewed and analyzed between April and June, 2020. Demographic, clinical and serological data were collected, as well as data on the anesthetic technique and intraoperative and postoperative complications. Results Of the 107 pregnant women with SARS-CoV-2 infection, 99 (92.52%) were asymptomatic and 8 (7.48%) had mild symptoms. The most frequent reasons for cesarean section were cephalo-pelvic disproportion in 20 (18.68%), previous cesarean section in 20 (18.68%) and non-reassuring fetal status in 14 (13.08%). Anesthesia technique was neuraxial in all cases, with spinal used in 100 (93.5%), combined spinal-epidural in 4 (3.7%) and epidural catheter in 3 (2.8%) patients. No deaths had occurred until the third postoperative day of follow-up. Conclusions The majority of pregnant women with SARS-CoV-2 infection are asymptomatic. In this work, spinal, combined spinal-epidural and epidural neuroxial anesthesia techniques were shown to be effective and safe for these patients and their newborn babies.


Resumen Introducción La información del comportamiento clínico, manejo anestésico y perioperatorio en gestantes con SARS-CoV-2 empieza a aparecer en la literatura mediante reportes de casos o serie de casos. Aún son limitadas la evidencia contundente y las recomendaciones. Objetivo Describir las características clínicas, resultados del manejo anestésico, perioperatorio y complicaciones en gestantes seroprevalentes para infección por SARS-CoV-2, cuyo parto fue por cesárea. Metodología Estudio observacional en el cual se revisaron y analizaron 107 historias clínicas de gestantes seroprevalentes para infección por SARS-CoV-2, de abril a junio del 2020. Se recolectaron datos demográficos, clínicos, serología, técnica anestésica y complicaciones intra y postoperatorias. Resultados De las 107 gestantes con infección por SARS-CoV-2, 99 (92,52 %) fueron asintomáticas y 8 (7,48 %) presentaron síntomas leves. Los motivos más frecuentes de cesárea fueron: desproporción céfalo-pélvica 20 (18,68 %), cesárea previa 20 (18,68 %) y estado fetal no tranquilizador 14 (13,08 %). La técnica anestésica fue neuro axial en su totalidad, espinal en 100 (93,5 %), combinada espinal-epidural en 4 (3,7 %) y epidural con catéter en 3 (2,8 %) pacientes. No se registraron muertes hasta el tercer día postoperatorio de seguimiento. Conclusiones Las gestantes con infección por SARS-CoV-2 presentan -en su mayoría- infecciones asintomáticas. En este trabajo, la anestesia neuro axial: espinal, combinada espinal-epidural y epidural, se presentan como técnicas efectivas y seguras para estas pacientes y sus recién nacidos.


Asunto(s)
Humanos , Femenino , Embarazo , Cesárea , SARS-CoV-2 , Anestesia , Perú , COVID-19 , Anestesia Epidural
8.
Ital J Pediatr ; 47(1): 220, 2021 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-34742332

RESUMEN

Coronavirus disease 2019 (COVID-19) affects all components of the respiratory system, including the neuromuscular breathing apparatus, conducting and respiratory airways, pulmonary vascular endothelium, and pulmonary blood flow. In contrast to other respiratory viruses, children have less severe symptoms when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A minority of children experience a post-infectious inflammatory syndrome, the pathology and long-term outcomes of which are poorly understood. The reason for the lower burden of symptomatic disease in children is not yet clear, but several pathophysiological characteristics are postulated. The SARS-CoV-2 pandemic has brought distinct challenges to the care of children globally. Proper recommendations have been proposed for a range of non-asthmatic respiratory disorders in children, including primary ciliary dyskinesia and cystic fibrosis. These recommendations involve the continuation of the treatment during this period and ways to maintain stability. School closures, loss of follow-up visit attendance, and loss of other protective systems for children are the indirect outcomes of measures to mitigate the COVID-19 pandemic. Moreover, COVID-19 has reshaped the delivery of respiratory care in children, with non-urgent and elective procedures being postponed, and distancing imperatives have led to rapid scaling of telemedicine. The pandemic has seen an unprecedented reorientation in clinical trial research towards COVID-19 and a disruption in other trials worldwide, which will have long-lasting effects on medical science. In this narrative review, we sought to outline the most recent findings on the direct and indirect effects of SARS-CoV-2 pandemic on pediatric respiratory chronic diseases other than asthma, by critically revising the most recent literature on the subject.


Asunto(s)
COVID-19/epidemiología , Control de Enfermedades Transmisibles/organización & administración , Atención a la Salud/organización & administración , Enfermedades Respiratorias/terapia , Adolescente , COVID-19/prevención & control , COVID-19/transmisión , Niño , Preescolar , Enfermedad Crónica , Humanos , Lactante , Recién Nacido , Enfermedades Respiratorias/complicaciones
9.
J Korean Acad Nurs ; 51(5): 511-524, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34737245

RESUMEN

The coronavirus disease 2019 (COVID-19) has emerged as a threat to human health and public safety. People of all ages are susceptible to severe acute respiratory syndrome coronavirus 2 infection. However, the clinical manifestations of this infection differ by age. This study purposes to describe healthcare considerations for special populations, such as children, pregnant and lactating women, and older adults, who may have unique healthcare needs, in the pandemic situation. To realize the research purpose, we conducted a review of the practice guidelines of public documents and qualified studies that were published online/offline during a specific period. The review identified current knowledge on care for newborns, children in schools, pregnant women (from antenatal to postpartum care), and older adults suffering from high-risk conditions. Subsequently, we summarize vaccination guidance for special populations and, finally, discuss the issues currently affecting special populations. Therefore, this current knowledge on care for special populations helps nurses to provide accurate information on vaccinations aimed at preventing COVID-19 and protecting the masses from infection. Currently, the scarcity of information on COVID-19 variants necessitates further research on measures to reduce pandemic spread.


Asunto(s)
COVID-19 , Complicaciones Infecciosas del Embarazo , Anciano , Niño , Atención a la Salud , Femenino , Humanos , Recién Nacido , Lactancia , Pandemias , Embarazo , SARS-CoV-2
10.
Health Technol Assess ; 25(61): 1-102, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34751645

RESUMEN

BACKGROUND: Around 60,000 babies are born preterm (prior to 37 weeks' gestation) each year in the UK. There is little evidence on the optimal birth mode (vaginal or caesarean section). OBJECTIVE: The overall aim of the CASSAVA project was to determine if a trial to define the optimal mode of preterm birth could be carried out and, if so, determine what sort of trial could be conducted and how it could best be performed. We aimed to determine the specific groups of preterm women and babies for whom there are uncertainties about the best planned mode of birth, and if there would be willingness to recruit to, and participate in, a randomised trial to address some, but not all, of these uncertainties. This project was conducted in response to a Heath Technology Assessment programme commissioning call (17/22 'Mode of delivery for preterm infants'). METHODS: We conducted clinician and patient surveys (n = 224 and n = 379, respectively) to identify current practice and opinion, and a consensus survey and Delphi workshop (n = 76 and n = 22 participants, respectively) to inform the design of a hypothetical clinical trial. The protocol for this clinical trial/vignette was used in telephone interviews with clinicians (n = 24) and in focus groups with potential participants (n = 13). RESULTS: Planned sample size and data saturation was achieved for all groups except for focus groups with participants, as this had to be curtailed because of the COVID-19 pandemic and data saturation was not achieved. There was broad agreement from parents and health-care professionals that a trial is needed. The clinician survey demonstrated a variety of practice and opinion. The parent survey suggested that women and their families generally preferred vaginal birth at later gestations and caesarean section for preterm infants. The interactive workshop and Delphi consensus process confirmed the need for more evidence (hence the case for a trial) and provided rich information on what a future trial should entail. It was agreed that any trial should address the areas with most uncertainty, including the management of women at 26-32 weeks' gestation, with either spontaneous preterm labour (cephalic presentation) or where preterm birth was medically indicated. Clear themes around the challenges inherent in conducting any trial emerged, including the concept of equipoise itself. Specific issues were as follows: different clinicians and participants would be in equipoise for each clinical scenario, effective conduct of the trial would require appropriate resources and expertise within the hospital conducting the trial, potential participants would welcome information on the trial well before the onset of labour and minority ethnic groups would require tailored approaches. CONCLUSION: Given the lack of evidence and the variation of practice and opinion in this area, and having listened to clinicians and potential participants, we conclude that a trial should be conducted and the outlined challenges resolved. FUTURE WORK: The CASSAVA project could be used to inform the design of a randomised trial and indicates how such a trial could be carried out. Any future trial would benefit from a pilot with qualitative input and a study within a trial to inform optimal recruitment. LIMITATIONS: Certainty that a trial could be conducted can be determined only when it is attempted. TRIAL REGISTRATION: Current Controlled Trials ISRCTN12295730. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 61. See the NIHR Journals Library website for further project information.


Around 60,000 babies are born preterm each year in the UK. We do not know what the safest mode of birth is for these babies. Birth options include a vaginal birth or a caesarean section (which involves an operation for the mother). Normally, the ideal way to find out what clinical options are best is to carry out a 'randomised trial' in which participants are allocated to a particular treatment group (in this case, vaginal birth or caesarean section) by chance. It is not clear if women who have their babies preterm would want to take part in such a trial or that the clinicians looking after the women would be happy to ask them to, as previous trials have failed to recruit sufficient participants. The purpose of the CASSAVA research project was to find out what people think is the best and safest method of delivering preterm babies, their views on doing a research trial and what sort of research trial could be carried out. We conducted a survey asking clinicians and women their views. We gathered clinicians and women together to discuss and agree the key questions for a trial to answer. We then developed a protocol (plan) for a possible trial. Using this trial protocol, we conducted telephone interviews with clinicians, asking them if they would be willing to be involved and if they would be willing to ask pregnant women to participate. We also conducted focus groups with women, using a vignette (storyboard) about a possible trial. We found that there is a lot of uncertainty about the best way for preterm babies to be born. Clinicians and women broadly agreed that it would be good to resolve this uncertainty through a trial. We were able to identify some areas of the greatest uncertainty where clinicians and women would consider participating in a study. We gained a lot of useful information about how we could best set up a trial and support clinicians and women to get involved.


Asunto(s)
COVID-19 , Manihot , Nacimiento Prematuro , Cesárea , Estudios de Factibilidad , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Pandemias , Embarazo , Nacimiento Prematuro/epidemiología , SARS-CoV-2
11.
Zhonghua Liu Xing Bing Xue Za Zhi ; 42(10): 1722-1749, 2021 Oct 10.
Artículo en Chino | MEDLINE | ID: mdl-34814607

RESUMEN

Influenza is a respiratory infectious disease that can seriously affect human health. Influenza virus has frequent antigenic drifts that can facilitate escape from pre-existing population immunity and lead to rapid and widespread transmission. Seasonal influenza is characterized by annual epidemics and outbreaks in places of public gathering such as schools, kindergartens, and nursing homes. According to the World Health Organization (WHO), seasonal influenza causes 3 to 5 million severe cases and 290 000 to 650 000 deaths globally each year. Pregnant women, young children, the elderly, and persons with chronic medical conditions are at highest risk for severe illness and death from influenza virus infection. With the ongoing COVID-19 pandemic, SARS-CoV-2 may co-circulate with influenza and other respiratory viruses in the upcoming winter-spring influenza season. Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and complications from influenza. China has several licensed influenza vaccines - trivalent inactivated influenza vaccines (IIV3), which include split-virus influenza vaccine and subunit vaccine; quadrivalent split-virus inactivated influenza vaccine (IIV4); and trivalent live attenuated influenza vaccine (LAIV3). With the exception of a few major cities, influenza vaccine is a non-program vaccine, which means that influenza vaccination is not included in China's Expanded Program on Immunization, and recipients must pay for influenza vaccine and its administration. China CDC has issued "Technical Guidelines for Seasonal Influenza Vaccination in China" every year from 2018 to 2020. This past year, there have been scientific and programmatic advances in prevention and control of seasonal influenza. To strengthen technical guidance for prevention and control of influenza and facilitate operational research on influenza vaccination, the National Immunization Advisory Committee (NIAC) Influenza Vaccination Technical Working Group (TWG) updated the 2020-2021 technical guidelines into the "Technical Guidelines for Seasonal Influenza Vaccination in China (2021-2022)." The new version has updates in five key areas: (1) new research evidence, especially from studies in China, on disease burden, vaccine effectiveness, vaccine-avoidable disease burden, vaccine safety monitoring, and cost-effectiveness and cost-benefit analyses, (2) policies and measures for influenza prevention and control that were issued by National Health Commission (NHC) in the past year, (3) licensure of a new seasonal influenza vaccine in time for the 2021-2022 season, (4) composition of the northern hemisphere trivalent and quadrivalent influenza vaccines for the 2021-2022 season, and (5) recommendations for influenza vaccination during the 2021-2022 influenza season. The recommendations specify that immunization clinics should provide influenza vaccine to all persons aged 6 months and above who are willing to be vaccinated and do not have contraindications; the interval between receipt of influenza vaccine and COVID-19 vaccine should at least 14 days; and there is no preference for one influenza vaccine over another for persons for whom more than one licensed, recommended, and appropriate vaccine is available. Considering the global COVID-19 pandemic and the need to decrease risk of influenza virus infection and minimize potential impact on COVID-19 prevention and control, we recommend the following target population priorities in preparation for the 2021-2022 influenza season: (1) healthcare workers, including clinical doctors and nurses, public health professionals, and quarantine professionals, (2) volunteers and staff who provide service and support for large events, (3) people living in nursing homes or welfare homes and staff who take care of vulnerable, at-risk individuals, (4) people who work in high population density settings, including teachers and students in kindergartens, primary, and secondary schools and prisoners and prison staff, and (5) people with high risk of complications from influenza, including adults ≥60 years of age, children 6-59 months of age, persons with certain chronic conditions, family members and caregivers of infants <6 months of age, and pregnant women and women who plan to become pregnant during the influenza season. Children 6 months through 8 years of age who have never received influenza vaccine or who have received only one lifetime dose require 2 doses of influenza vaccine that are administered at least 4 weeks apart. This recommendation applies to both IIV and LAIV. If children received 2 doses of influenza vaccine in the 2020-2021 influenza season or received more than 2 doses of influenza vaccine in prior influenza seasons, 1 dose of influenza vaccine is recommended. People more than 9 years old require only 1 dose of influenza vaccine. People should receive influenza vaccination by the end of October, and influenza vaccine should be offered as soon as it is available. For people unable to be vaccinated before the end of October, influenza vaccine will continue to be offered throughout the season. Influenza vaccine is recommended for pregnant women during any trimester of pregnancy. These guidelines are intended for use by staff of CDCs at all levels who work on influenza control and prevention; immunization clinic staff members; healthcare workers from departments of pediatrics, internal medicine, and infectious diseases; and staff of maternity and child care institutions at all levels. The guidelines will be periodically updated as new evidence becomes available.


Asunto(s)
COVID-19 , Gripe Humana , Anciano , Vacunas contra la COVID-19 , Niño , Preescolar , China/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Gripe Humana/epidemiología , Gripe Humana/prevención & control , Pandemias , Embarazo , SARS-CoV-2 , Estaciones del Año , Vacunación
12.
MMWR Morb Mortal Wkly Rep ; 70(46): 1603-1607, 2021 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-34793421

RESUMEN

During October 3, 2020-January 9, 2021, North Carolina experienced a 400% increase in daily reported COVID-19 cases (1). To handle the increased number of cases and rapidly notify persons receiving a positive SARS-CoV-2 test result (patients), North Carolina state and local health departments moved from telephone call notification only to telephone call plus automated text and email notification (digital notification) beginning on December 24, 2020. Overall, among 200,258 patients, 142,975 (71%) were notified by telephone call or digital notification within the actionable period (10 days from their diagnosis date)* during January 2021, including at least 112,543 (56%) notified within 24 hours of report to North Carolina state and local health departments, a significantly higher proportion than the 25,905 of 175,979 (15%) notified within 24 hours during the preceding month (p<0.001). Differences in text notification by age, race, and ethnicity were observed. Automated digital notification is a feasible, rapid and efficient method to support timely outreach to patients, provide guidance on how to isolate, access resources, inform close contacts, and increase the efficiency of case investigation staff members.


Asunto(s)
Automatización , COVID-19/diagnóstico , Correo Electrónico , Envío de Mensajes de Texto , Adolescente , Adulto , Anciano , COVID-19/epidemiología , COVID-19/prevención & control , Prueba de COVID-19 , Niño , Preescolar , Notificación de Enfermedades/métodos , Notificación de Enfermedades/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , North Carolina/epidemiología , Factores de Tiempo , Adulto Joven
13.
PLoS Med ; 18(11): e1003857, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34847147

RESUMEN

BACKGROUND: To the best of our knowledge, no study has exhaustively evaluated the association between maternal morbidities and Coronavirus Disease 2019 (COVID-19) during the first wave of the pandemic in pregnant women. We investigated, in natural conceptions and assisted reproductive technique (ART) pregnancies, whether maternal morbidities were more frequent in pregnant women with COVID-19 diagnosis compared to pregnant women without COVID-19 diagnosis during the first wave of the COVID-19 pandemic. METHODS AND FINDINGS: We conducted a retrospective analysis of prospectively collected data in a national cohort of all hospitalizations for births ≥22 weeks of gestation in France from January to June 2020 using the French national hospitalization database (PMSI). Pregnant women with COVID-19 were identified if they had been recorded in the database using the ICD-10 (International Classification of Disease) code for presence of a hospitalization for COVID-19. A total of 244,645 births were included, of which 874 (0.36%) in the COVID-19 group. Maternal morbidities and adverse obstetrical outcomes among those with or without COVID-19 were analyzed with a multivariable logistic regression model adjusted on patient characteristics. Among pregnant women, older age (31.1 (±5.9) years old versus 30.5 (±5.4) years old, respectively, p < 0.001), obesity (0.7% versus 0.3%, respectively, p < 0.001), multiple pregnancy (0.7% versus 0.4%, respectively, p < 0.001), and history of hypertension (0.9% versus 0.3%, respectively, p < 0.001) were more frequent with COVID-19 diagnosis. Active smoking (0.2% versus 0.4%, respectively, p < 0.001) and primiparity (0.3% versus 0.4%, respectively, p < 0.03) were less frequent with COVID-19 diagnosis. Frequency of ART conception was not different between those with and without COVID-19 diagnosis (p = 0.28). When compared to the non-COVID-19 group, women in the COVID-19 group had a higher frequency of admission to ICU (5.9% versus 0.1%, p < 0.001), mortality (0.2% versus 0.005%, p < 0.001), preeclampsia/eclampsia (4.8% versus 2.2%, p < 0.001), gestational hypertension (2.3% versus 1.3%, p < 0.03), postpartum hemorrhage (10.0% versus 5.7%, p < 0.001), preterm birth at <37 weeks of gestation (16.7% versus 7.1%, p < 0.001), <32 weeks of gestation (2.2% versus 0.8%, p < 0.001), <28 weeks of gestation (2.4% versus 0.8%, p < 0.001), induced preterm birth (5.4% versus 1.4%, p < 0.001), spontaneous preterm birth (11.3% versus 5.7%, p < 0.001), fetal distress (33.0% versus 26.0%, p < 0.001), and cesarean section (33.0% versus 20.2%, p < 0.001). Rates of pregnancy terminations ≥22 weeks of gestation, stillbirths, gestational diabetes, placenta praevia, and placenta abruption were not significantly different between the COVID-19 and non-COVID-19 groups. The number of venous thromboembolic events was too low to perform statistical analysis. A limitation of this study relies in the possibility that asymptomatic infected women were not systematically detected. CONCLUSIONS: We observed an increased frequency of pregnant women with maternal morbidities and diagnosis of COVID-19 compared to pregnant women without COVID-19. It appears essential to be aware of this, notably in populations at known risk of developing a more severe form of infection or obstetrical morbidities and in order for obstetrical units to better inform pregnant women and provide the best care. Although causality cannot be determined from these associations, these results may be in line with recent recommendations in favor of vaccination for pregnant women.


Asunto(s)
COVID-19/epidemiología , Cesárea/estadística & datos numéricos , Pandemias , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo , Nacimiento Prematuro/epidemiología , Adulto , Diabetes Gestacional/epidemiología , Femenino , Sufrimiento Fetal/epidemiología , Francia/epidemiología , Humanos , Hipertensión Inducida en el Embarazo/epidemiología , Recién Nacido , Unidades de Cuidados Intensivos , Modelos Logísticos , Mortalidad Materna , Obesidad/epidemiología , Hemorragia Posparto/epidemiología , Preeclampsia/epidemiología , Embarazo , Mujeres Embarazadas , Estudios Retrospectivos , SARS-CoV-2
14.
Front Immunol ; 12: 777103, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34804068

RESUMEN

Background: Data regarding symptoms in the lactating mother-infant dyad and their immune response to COVID-19 mRNA vaccination during lactation are needed to inform vaccination guidelines. Methods: From a prospective cohort of 50 lactating individuals who received mRNA-based vaccines for COVID-19 (mRNA-1273 and BNT162b2), blood and milk samples were collected prior to first vaccination dose, immediately prior to 2nd dose, and 4-10 weeks after 2nd dose. Symptoms in mother and infant were assessed by detailed questionnaires. Anti-SARS-CoV-2 antibody levels in blood and milk were measured by Pylon 3D automated immunoassay and ELISA. In addition, vaccine-related PEGylated proteins in milk were measured by ELISA. Blood samples were collected from a subset of infants whose mothers received the vaccine during lactation (4-15 weeks after mothers' 2nd dose). Results: No severe maternal or infant adverse events were reported in this cohort. Two mothers and two infants were diagnosed with COVID-19 during the study period before achieving full immune response. PEGylated proteins were not found at significant levels in milk after vaccination. After vaccination, levels of anti-SARS-CoV-2 IgG and IgM significantly increased in maternal plasma and there was significant transfer of anti-SARS-CoV-2-Receptor Binding Domain (anti-RBD) IgA and IgG antibodies to milk. Milk IgA levels after the 2nd dose were negatively associated with infant age. Anti-SARS-CoV-2 IgG antibodies were not detected in the plasma of infants whose mothers were vaccinated during lactation. Conclusions: COVID-19 mRNA vaccines generate robust immune responses in plasma and milk of lactating individuals without severe adverse events reported.


Asunto(s)
Anticuerpos Antivirales/inmunología , Vacunas contra la COVID-19/administración & dosificación , Lactancia/inmunología , Leche Humana/inmunología , SARS-CoV-2/inmunología , Vacuna nCoV-2019 mRNA-1273 , Adulto , Anticuerpos Antivirales/sangre , Vacuna BNT162 , COVID-19/prevención & control , Femenino , Humanos , Inmunoglobulina A/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad
15.
Int J Clin Pract ; 75(12): e15012, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34806816

RESUMEN

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people around the world, with most cases recorded among adults. The cases reported among children have been acknowledged to be minimal in comparison to adults. Nevertheless, coronavirus disease 2019 (COVID-19) has been reported to affect children of all ages, including newborns. The symptoms among children have also been identified to be similar to those observed among adults, although paediatric patients have been noted to display a spectrum of clinical features ranging from asymptomatic to moderate symptoms. Despite ample publications on the ongoing pandemic, the literature is only replete with guidelines on treating SARS-CoV-2 infection among older people. In this narrative review, comprehensive updates on the infection in children have been discussed. The latest information on the spread of the disease among children around the world, the clinical features observed among the paediatric population, as well as recommended pharmaceutical treatments of COVID-19 among this special group of patients have been covered. Further, expert consensus statements regarding the management of this highly contagious disease among pregnant women and neonates have been discussed. It is believed that this comprehensive review will provide updated information on the epidemiology and clinical features of the ongoing pandemic among paediatric patients. Additionally, the guidelines for handling SARS-CoV-2 among pregnant women and children, as reviewed in this article, are anticipated to be useful to frontline clinicians battling this fatal disease around the globe.


Asunto(s)
COVID-19 , Adulto , Anciano , Niño , Femenino , Humanos , Recién Nacido , Pandemias , Embarazo , SARS-CoV-2
16.
Acta Biomed ; 92(S7): e2021524, 2021 11 29.
Artículo en Inglés | MEDLINE | ID: mdl-34842595

RESUMEN

SARS-CoV-2 infection has a severe course in a small percentage of children. Remdesivir has shown promising results in reducing hospitalisation time in adults, but data on mortality rate are conflicting and few studies are available on its use use in antivirals in children. We performed a quick narrative review of the available literature data regarding the usage of remdesivir in children and neonates. In children, remdesivir showed good safety profile, however bradicardia events have been reported in children. Remdesivir is currently recommended by several guidelines in some subgroups of children with severe COVID-19, and should also be considered in critically ill patients, always in the context of the overall clinical picture and drug availability.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , Adenosina Monofosfato/análogos & derivados , Adulto , Alanina/análogos & derivados , Niño , Humanos , Recién Nacido , SARS-CoV-2
17.
BMJ Paediatr Open ; 5(1): e001156, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34632107

RESUMEN

Around the world, one in four children live in a country affected by conflict, political insecurity and disaster. Healthcare in humanitarian and fragile settings is challenging and complex to provide, particularly for children. Furthermore, there is a distinct lack of medical literature from humanitarian settings to guide best practice in such specific and resource-limited contexts. In light of these challenges, Médecins Sans Frontières (MSF), an international medical humanitarian organisation, created the MSF Paediatric Days with the aim of uniting field staff, policymakers and academia to exchange ideas, align efforts, inspire and share frontline research and experiences to advance humanitarian paediatric and neonatal care. This 2-day event takes place regularly since 2016. The fourth edition of the MSF Paediatric Days in April 2021 covered five main topics: essential newborn care, community-based models of care, paediatric tuberculosis, antimicrobial resistance in neonatal and paediatric care and the collateral damage of COVID-19 on child health. In addition, eight virtual stands from internal MSF initiatives and external MSF collaborating partners were available, and 49 poster communications and five inspiring short talks referred to as 'PAEDTalks' were presented. In conclusion, the MSF Paediatric Days serves as a unique forum to advance knowledge on humanitarian paediatrics and creates opportunities for individual and collective learning, as well as networking spaces for interaction and exchange of ideas.


Asunto(s)
COVID-19 , Misiones Médicas , Pediatría , Niño , Atención a la Salud , Humanos , Recién Nacido , SARS-CoV-2
19.
Adv Neonatal Care ; 21(6): 482-492, 2021 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-34596092

RESUMEN

BACKGROUND: This case describes a case of vertical transmission of COVID-19 from a mother to her neonate. The neonate subsequently developed acute respiratory failure consistent with adult symptoms of COVID-19. CLINICAL FINDINGS: This preterm neonate was born at 33 4/7 weeks' gestational age to a COVID-19-positive mother and admitted to the neonatal intensive care unit (NICU) for prematurity and respiratory distress. The neonate developed acute respiratory failure with severe persistent pulmonary hypertension of newborn (PPHN) and required intubation and maximum respiratory and cardiovascular support. The neonate subsequently tested positive for COVID-19 at 24 hours of life. PRIMARY DIAGNOSIS: Acute respiratory failure related to COVID-19 infection. INTERVENTIONS: The neonate was admitted to the NICU on CPAP. At 11 hours of life, the neonate began to exhibit signs of worsening respiratory distress requiring intubation, mechanical, and high frequency ventilation. An echocardiogram revealed severe PPHN. The neonate required dopamine to manage hypotension and was treated with steroids to decrease inflammation associated with airway edema noted during intubation. Pharmaceutically induced paralysis, analgesia, and sedation was used to manage persistent hypoxia. OUTCOMES: The neonate fully recovered from acute respiratory failure and was discharged home with the mother. PRACTICE RECOMMENDATIONS: Newborns born to mothers who are positive for COVID-19 are at risk for vertical transmission of COVID-19 and should be monitored closely for acute respiratory failure. Respiratory medical management should include supportive care. Staff should also encourage parents to consider receiving the COVID-19 vaccine to protect their newborn from the possibility of developing acute respiratory failure.


Asunto(s)
COVID-19 , Síndrome de Dificultad Respiratoria , Insuficiencia Respiratoria , Adulto , Vacunas contra la COVID-19 , Femenino , Humanos , Recién Nacido de Bajo Peso , Recién Nacido , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/terapia , SARS-CoV-2
20.
BMJ Open ; 11(10): e054410, 2021 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-34598993

RESUMEN

OBJECTIVES: The COVID-19 pandemic instigated multiple societal and healthcare interventions with potential to affect perinatal practice. We evaluated population-level changes in preterm and full-term admissions to neonatal units, care processes and outcomes. DESIGN: Observational cohort study using the UK National Neonatal Research Database. SETTING: England and Wales. PARTICIPANTS: Admissions to National Health Service neonatal units from 2012 to 2020. MAIN OUTCOME MEASURES: Admissions by gestational age, ethnicity and Index of Multiple Deprivation, and key care processes and outcomes. METHODS: We calculated differences in numbers and rates between April and June 2020 (spring), the first 3 months of national lockdown (COVID-19 period), and December 2019-February 2020 (winter), prior to introduction of mitigation measures, and compared them with the corresponding differences in the previous 7 years. We considered the COVID-19 period highly unusual if the spring-winter difference was smaller or larger than all previous corresponding differences, and calculated the level of confidence in this conclusion. RESULTS: Marked fluctuations occurred in all measures over the 8 years with several highly unusual changes during the COVID-19 period. Total admissions fell, having risen over all previous years (COVID-19 difference: -1492; previous 7-year difference range: +100, +1617; p<0.001); full-term black admissions rose (+66; -64, +35; p<0.001) whereas Asian (-137; -14, +101; p<0.001) and white (-319; -235, +643: p<0.001) admissions fell. Transfers to higher and lower designation neonatal units increased (+129; -4, +88; p<0.001) and decreased (-47; -25, +12; p<0.001), respectively. Total preterm admissions decreased (-350; -26, +479; p<0.001). The fall in extremely preterm admissions was most marked in the two lowest socioeconomic quintiles. CONCLUSIONS: Our findings indicate substantial changes occurred in care pathways and clinical thresholds, with disproportionate effects on black ethnic groups, during the immediate COVID-19 period, and raise the intriguing possibility that non-healthcare interventions may reduce extremely preterm births.


Asunto(s)
COVID-19 , Pandemias , Estudios de Cohortes , Control de Enfermedades Transmisibles , Inglaterra/epidemiología , Femenino , Humanos , Recién Nacido , Embarazo , SARS-CoV-2 , Medicina Estatal , Gales/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...